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Peripheral sensory neurons respond to axon injury
by activating an importin-dependent retrograde sig-
naling mechanism. How is this mechanism regu-
lated? Here, we show that Ran GTPase and its asso-
ciated effectors RanBP1 and RanGAP regulate the
formation of importin signaling complexes in injured
axons. A gradient of nuclear RanGTP versus cyto-
plasmic RanGDP is thought to be fundamental for
the organization of eukaryotic cells. Surprisingly,
we find RanGTP in sciatic nerve axoplasm, distant
from neuronal cell bodies and nuclei, and in associa-
tion with dynein and importin-a. Following injury, lo-
calized translation of RanBP1 stimulates RanGTP
dissociation from importins and subsequent hydroly-
sis, thereby allowing binding of newly synthesized
importin-b to importin-a and dynein. Perturbation
of RanGTP hydrolysis or RanBP1 blockade at axonal
injury sites reduces the neuronal conditioning lesion
response. Thus, neurons employ localized mecha-
nisms of Ran regulation to control retrograde injury
signaling in peripheral nerve.
INTRODUCTION
The cell body of a lesioned neuron must receive accurate and
timely information on axonal injury in order to activate repair
mechanisms. Early work in Aplysia suggested that retrograde in-
jury signals originating in the axon are transported retrogradely
to the cell body in a nuclear localization signal (NLS)-dependent
manner (Ambron and Walters, 1996). Nuclear import of proteins
is mediated by NLS binding to the importins, soluble transport
factors that mediate the translocation of substrates through
the nuclear pore complex (Harel and Forbes, 2004; Weis,
2003). We have shown that importins are found in rodent nerveaxons and that they enable retrograde transport of injury-signal-
ing proteins. Importin-a is found in axons of both control and
injured sciatic nerve in constitutive association with dynein. In
contrast, importin-b protein is not detectable under normal
conditions in sciatic nerve axoplasm, although its mRNA is found
in intermittent local concentrations throughout the axons (Hanz
et al., 2003). Upon lesion, this mRNA is rapidly translated into im-
portin-b protein, leading to the formation of importin-a/b hetero-
dimers bound to the retrograde motor dynein, thereby creating
high affinity NLS binding sites linked to the retrograde transport
machinery. Introduction of excess NLS peptides into lesioned
DRG axons inhibited conditioning lesion responses in vivo
(Hanz et al., 2003). Further work showed that soluble forms of
the type III intermediate filament vimentin are also elevated by lo-
cal translation and then undergo calpain-mediated cleavage in
sciatic nerve axoplasm after injury (Perlson et al., 2005; Perlson
et al., 2004). Vimentin binds phosphorylated Erk (pErk) in a cal-
cium-dependent manner (Perlson et al., 2006) and links the acti-
vated MAP kinase to the retrograde transport system via direct
binding of vimentin to importin-b. Upon arrival in the cell body,
pErk activates the transcription factor Elk1 (Perlson et al., 2005),
thus importins enable coupling of axonal injury to specific tran-
scriptional responses in the cell body. Since activation of axonal
importins has far-reaching consequences for the neuron, how
might this be regulated?
Classical nuclear transport is tightly regulated by the small
GTPase Ran, which cycles between a GTP bound form prevalent
in the nucleus, and a GDP-bound form in the cytoplasm (Kalab
and Heald, 2008; Weis, 2003). This asymmetric distribution reg-
ulates cargo interactions with importins, since RanGDP does not
bind importins, while the GTP form interacts directly with impor-
tin-b and indirectly via CAS with importin-a (see Figure S1 avail-
able online). The importins are exported from the nucleus in as-
sociation with RanGTP. In the cytosol, competitive binding of
RanBP1 releases RanGTP from the importins, and rebinding is
prevented by RanGAP-mediated hydrolysis of Ran to the GDP-
bound state (Kalab and Heald, 2008; Poon and Jans, 2005).
The fundamental roles of Ran in regulating importin-dependentNeuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc. 241
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Ran Controls Axonal Retrograde Injury SignalingFigure 1. Ran and Associated Proteins Are Found in Neuronal
Processes in the Sciatic Nerve
(A) Western blot analysis of sciatic nerve axoplasm shows similar levels of Ran
and CAS before and 2, 4, and 6 hr after injury. RanBP1 is significantly in-
creased and RanGAP is slightly upregulated over the same time period. Immu-
noprecipitation of RanGAP and western with anti-Sumo reveals that a signifi-
cant proportion of the axonal RanGAP is sumoylated. H denotes HeLa cell
extract, used as a positive control. 40 mg protein per lane.242 Neuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc.nuclear import prompted us to ask if it might also be involved
in regulating importins in axons. Here, we show that the
RanGTPase system regulates the formation of retrograde impor-
tin signaling complexes in the axons of injured peripheral neu-
rons. Surprisingly, RanGTP is found in axonal cytoplasm in the
sciatic nerve, distant from neuronal cell bodies and nuclei, and
in association with CAS, importin-a, and dynein. Following injury,
localized translation of RanBP1 stimulates RanGTP dissociation
from importins and subsequent hydrolysis, thereby allowing
binding of newly synthesized importin-b to importin-a and
dynein. Thus, localized mechanisms of Ran regulation allow
neurons to control importin-cargo interactions at axonal sites
distant from the nucleus.
RESULTS
We used Western blots to screen axonal cytoplasm (axoplasm)
from adult rat sciatic nerve for the presence of nuclear transport
regulating proteins. Axoplasm purity was verified by western
blotting for the RanGEF RCC1, which serves as a nuclear
marker, and glial markers such as S100 and GFAP (Hanz et al.,
2003; Perlson et al., 2005; Figure S2). Ran and the adaptor pro-
tein CAS were both found in sciatic nerve axoplasm, and the
levels of these proteins were not markedly affected by injury
(Figure 1A). In contrast, RanBP1 levels were very low in uninjured
nerve, and significantly upregulated after lesion. Soluble
RanGAP levels in axoplasm also appeared to be regulated by
injury, albeit more modestly than RanBP1. A large fraction of
the axonal RanGAP migrated as a higher molecular mass band
on the blots in both control and injured nerve, and this was found
to represent a sumoylated form of the protein (Figure 1A), as pre-
viously described in other systems (Pichler and Melchior, 2002).
Interestingly, sumoylation was recently shown to regulate retro-
grade transport of an RNA-binding protein in axons (van Niekerk
et al., 2007). In order to verify that the observed proteins are
indeed found in axons, we performed immunostaining for Ran,
RanBP1, and RanGAP on cross-sections of injured sciatic nerve
and on cultures of regenerating adult sensory neurons from the
L4/L5 dorsal root ganglia (DRG) that project axons into the sci-
atic nerve. As shown in Figures 1B and 1C, all three proteins
are found within regenerating neurites in vitro and in injured
axons in vivo, whereas RCC1 is restricted to the nuclei of cul-
tured DRG neurons (Figure S2). Higher magnification immuno-
staining on sciatic nerve cross-sections also supports RanBP1
upregulation within axons after injury (Figure 1D).
Next, we examined the association of Ran with components of
the retrograde injury-signaling complex. Throughout these stud-
ies we used antibodies against importin-a4 and importin-b1, re-
ferred to hereafter as importin-a and importin-b for simplicity.
(B) Immunostaining for Ran, RanBP1, RanGAP, and the axonal marker NF-H
on adult DRG neurons in culture shows that all three proteins are found in
NF-H-positive axons.
(C) Immunostaining for Ran, RanBP1 and RanGAP in cross-sections of injured
sciatic nerve reveals the presence of all three proteins in NF-H-positive axons.
Magnification 403.
(D) Immunostaining for RanBP1 on cross-sections of control versus injured
(6 hr post-lesion) sciatic nerve. Magnification 603.
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Ran Controls Axonal Retrograde Injury SignalingImportin-a coprecipitates with Ran in control but not in injured
nerve (Figure 2A). Importin-awas previously shown to be consti-
tutively bound to dynein in uninjured nerve (Hanz et al., 2003),
and indeed dynein was also coprecipitated with Ran in control
but not in injured nerves (Figure 2A). Ran normally interacts
with importin-a only via the adaptor CAS, and immunoprecipita-
tion of Ran from sciatic nerve axoplasm shows an association of
CAS with Ran in control but not in injured nerves (Figure 2A). No-
tably, Ran must be in its GTP-bound form for interaction with
CAS and importin-a (Quimby and Dasso, 2003; Weis, 2003).
Hence, these data suggest that uninjured sciatic nerve axons
contain RanGTP in vivo, which is striking given the distance of
Figure 2. RanGTP in Sciatic Nerve Axoplasm
(A) Ran is associated with importin-a through CAS in control but not in injured
nerves. Importin-a, dynein intermediate chain, and CAS are coprecipitated
with Ran in control but not after injury, although equal amounts of Ran were
precipitated in all samples. One milligram protein was used per i.p. Input in
this panel is a 10% loading control probed for dynein intermediate chain.
(B) Pull-down of Ran by importin-b. Purified recombinant importin-b and Ran
were incubated together after preloading of Ran with GDP or with GTP. Impor-
tin-bwas then immunoprecipitated, and coprecipitated Ran was monitored by
western blot. Only RanGTP coprecipitated with importin-b. Input control in this
and all subsequent panels is Ran.
(C) Sciatic nerve axoplasm (250 mg) was charged with recombinant importin-b,
and incubated as described before precipitation of importin-b. Ran content in
the precipitates was examined by western blot.
(D) Quantification of the experiment described in (C) shows that levels of
RanGTP in axoplasm are significantly reduced following injury (average ± stan-
dard deviation, n = 3, * denotes p < 0.05, ** denotes p < 0.01, Student’s t test).
(E) Immunoprecipitation of RanGTP from axoplasm with the ARAN1 antibody.
Sciatic nerve axoplasm (200 mg) was precipitated with 10 mg each of His-im-
portin-b and ARAN1 antibody. Precipitated RanGTP was visualized on western
blot with rabbit anti-Ran (Abcam).these processes (5 cm) from neuronal nuclei. In order to con-
firm this observation, we carried out pull-downs of Ran from axo-
plasm with exogenously added His-tagged importin-b1, after
first verifying in vitro that recombinant His-importin-b binds spe-
cifically to RanGTP, but not RanGDP (Figure 2B). Endogenous
axonal RanGTP was coprecipitated with His-importin-b from
control nerve (Figure 2C). The proportion of RanGTP from total
Ran was reduced rapidly following lesion, reaching approxi-
mately half control levels 60–90 min after a crush injury (Fig-
ure 2D). We also used the ARAN1 antibody (Hieda et al., 1999)
to verify this result. The C-terminal epitope in Ran that is recog-
nized by ARAN1 is exposed only when Ran is bound to importin-
b. ARAN1 immunoprecipitation of axoplasm charged with
importin-b confirmed precipitation of RanGTP (Figure 2E).
RanBP1 triggers the hydrolysis of RanGTP to RanGDP by dis-
placing bound importins from RanGTP in concert with RanGAP.
The low levels of RanBP1 in uninjured axons in vivo should there-
fore facilitate maintenance of RanGTP, and RanBP1 upregula-
tion upon injury is likely to be important for releasing importins
for cargo binding in lesioned axons. We therefore examined
the mode of upregulation of RanBP1 protein in axoplasm after in-
jury. Previous studies have shown that a number of different pro-
teins, including importin-b1, are synthesized by local translation
from axonal mRNA after nerve injury (Wang et al., 2007; Willis
et al., 2005, 2007). Injury causes increase in axonal calcium
levels (Mandolesi et al., 2004; Petrescu et al., 2007), and calcium
was previously shown to regulate binding interactions within the
retrograde injury signaling complex (Perlson et al., 2006). As
demonstrated in Figure 3, the local synthesis of importin-b1 in
injured axons can be blocked by the calcium chelator EGTA
as well as by the translation inhibitor cycloheximide. Similar find-
ings were observed for the injury-induced elevation in RanBP1
levels, but not for the more modest elevation of soluble RanGAP
(Figures 3A–3C). Indeed a RanBP1 transcript could be amplified
by RT-PCR from isolated DRG axons, while no RT-PCR products
were obtained for RanGAP (Figure 3D). Further confirmation for
the occurrence of RanBP1 transcripts in axons was also ob-
tained by fluorescent in situ hybridization (FISH) on cultured
DRG neurons (Figures 3E and S3).
Transport of specific transcripts into axons is usually con-
trolled by untranslated sequences (UTR) that interact with RNA
transport proteins (Bassell and Kelic, 2004). We therefore carried
out 30RACE RT-PCR on RNA extracted from DRGs and from
axoplasm to identify and clone RanBP1 30UTR sequences.
Two main variants of RanBP1 30UTR were identified, a short
form of 94 bases and a longer 302 bases sequence (Figures
4A and S4). These UTR sequences did not contain any known lo-
calization motifs; hence, we tested their capacity to induce axo-
nal localization of a reporter gene. DRG neurons were trans-
fected with constructs containing RanBP1 UTR sequences
fused to a GFP-encoding open reading frame, and FISH was
carried out to localize the GFP transcripts. Axonal localization
of transcript was observed in approximately 55% of neurons
transfected with constructs containing the long UTR, while tran-
scripts containing the short UTR were mainly restricted to the cell
body (Figure 4B).
In order to further verify axon localization with RanBP1 UTR
sequences, both UTR variants were fused to a previouslyNeuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc. 243
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Ran Controls Axonal Retrograde Injury Signalingdescribed destabilized and myristoylated GFP reporter (Aakalu
et al., 2001; Smith et al., 2005). Importantly, fusion of the myris-
toylation sequence to GFP limits diffusion of newly synthesized
protein, allowing its use as a reliable reporter of localized protein
synthesis after photobleaching (Aakalu et al., 2001; Willis et al.,
2007). An additional construct comprised the differential seg-
ment between the long and short UTR forms (schematic in
Figure 4A). All three constructs were transfected into cultured
Figure 3. RanBP1 and Importin-b Are Locally Synthesized in a
Calcium-Dependent Manner after Nerve Injury
Western blot analyses of axoplasm (40 mg protein per lane for importin-b or
RanGAP, 100 mg for RanBP1) shows that the upregulation of importin-b and
RanBP1 is blocked by (A) injection of the translation inhibitor cycloheximide
(CHX) or (B) the calcium chelator EGTA to the sciatic nerve concomitantly
with nerve crush. RanGAP upregulation is not influenced by either reagent.
Erk is used as a loading control.
(C) Densitometric quantification of the experiments shown in (A) and (B), Vehi-
cle in pink, EGTA in red, and CHX in black; all normalized as % of the highest
value observed in each experiment (average ± standard deviation, n = 3).
(D) RT-PCR on isolated DRG axons amplifies RanBP1 transcript from axons,
but not RanGAP mRNA. RT-PCR for b-actin (a known axonal transcript) and
g-actin (a soma-restricted transcript) provide positive and negative controls,
respectively.
(E) Fluorescent in situ hybridization (FISH) on DRG cultures reveals the pres-
ence of RanBP1 transcript (red) in an axon identified by immunostaining for
neurofilament heavy chain (NFH, green). The panel shows high magnification
of a single axon segment (scale bar 5 mm); note the granular signal for RanBP1
mRNA. For additional FISH images, see Figure S2.244 Neuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc.DRG neurons for FRAP (fluorescence recovery after photo-
bleaching) analyses. In these experiments, a portion of the
axon expressing the fluorescent GFP reporter is bleached, and
recovery of fluorescence is monitored over a period of 20 min.
This time scale allows observation of recovery due to localized
synthesis but is not long enough for transport or diffusion of
myristoylated reporter protein from the soma to the bleached
region (Aakalu et al., 2001 and data not shown). Fluorescence re-
covery was observed for constructs containing the long form of
RanBP1 30UTR, but not for the short UTR variant (Figures 4C, 4D,
and S5; Movies S1 and S3). The average prebleach fluorescent
signal in distal axons was approximately two-fold higher for the
long form of RanBP1 30UTR as compared with the short UTR var-
iant (36.2 ± 2.5 versus 17.4 ± 0.5 pixels/mm2; p% 0.001). The re-
covery observed for the long 30UTR construct was blocked upon
incubation with the translation inhibitor anisomycin, consistent
with the new fluorescence signal arising from local translation
in the axon (Figures 4C, 4D, and S5; Movie S2). Moreover, the
calculated time for complete recovery to prebleach fluorescence
intensities for dzGFP fused to the full-length RanBP1 UTR is 49 min
(±2.9 min) based on linear regression (correlation coefficient =
0.98), versus 478 ± 62.9 min (correlation coefficient = 0.88) for
the identical dzGFP reporter fused to the short RanBP1 30UTR.
Since the only difference between these two constructs is the
axon-localizing segment in the long UTR, the rapid recovery
must arise from axonally localized transcript. Similar results
were obtained with the differential segment construct (Figures
4C, 4D, and S5; Movies S4 and S5), confirming that axon-target-
ing motifs are localized within the distal segment of the longer
form of RanBP1 30UTR.
As noted above, 100% of dzGFP from the long RanBP1 30UTR
construct is locally synthesized in a time period that allows for
less than 10% recovery from other sources. Nonetheless, to es-
tablish this point beyond doubt, the question whether cell body
synthesis could play a role was addressed by FRAP experiments
on cut axons physically disconnected from cell bodies (Figures
4E and 4F). Lesioned DRG axons retain protein synthetic capac-
ity for several hours in vitro after severing their connection to the
cell body (Willis et al., 2005; Zheng et al., 2001). After cutting the
axon with a glass microelectrode, the proximal and distal cut
ends retract slightly over 5–10 min (Zheng et al., 2001), such
that the distal cut axon is clearly separated from the proximal
segment by a few microns. Recovery of myr-dzGFP-30UTR-
RanBP1 in the cut axons occurs with similar initial kinetics as ob-
served for whole axons (Figures 4E and 4F). The reduced recov-
ery rate observed at later time points is most likely due to the fact
that neuronal processes rapidly degenerate after separation
from the cell body by this cutting approach (Aakalu et al.,
2001). Even so, the calculated time to full recovery based on
the initial kinetics is 122 min (±22 min), well within the range for
physiological significance (see Discussion).
To further address the possibility of anterograde transport of
dzGFP from proximal regions, we transfected DRG neurons
with myr-dzGFP-30UTR-RanBP1 and Kif5C560-dTomato, a
kinesin mutant that selectively accumulates in axonal growth
cones through anterograde transport (Jacobson et al., 2006).
Photobleached growth cones from these neurons showed
statistically significant recovery of myr-GFP but not of
Neuron
Ran Controls Axonal Retrograde Injury SignalingFigure 4. A Long Variant 30UTR Targets
RanBP1 to the Axon
(A) Schematic of RanBP1 transcripts, with open
reading frame denoted by the green box. The lines
under the schematic delineate regions subcloned
for constructs containing long (L) or short (S)
30UTR variants, or the differential segment (D)
found in the long but not in the short UTR.
(B) Representative confocal images of in situ hy-
bridization on adult DRG neurons with a GFP ri-
boprobe following Amaxa nucleofection with the
indicated constructs. White arrows indicate signal
in the neurites. Scale bar is 20 mm.
(C) Representative images from time-lapse se-
quences of photobleach experiments before
(2 min) and after photobleaching (0 and 18 min)
of adult DRG neurons transfected with the indi-
cated constructs. The boxed regions represent
the area subjected to photobleaching with recov-
ery monitored over 18 min. (More detailed image
series are shown in Figure S5 and in the Supple-
mental Movies). Arrows indicate growth cones.
Anis. indicates transfected neurons that were
treated with 1 mM anisomycin immediately prior
to prebleach imaging (see also Figure S5).
(D) Fluorescence intensity over multiple time-lapse
sequences. Average recoveries (% of pre-bleach
levels ± SEM) are shown (n = 4–6). Significant
recovery after photobleaching assessed by two-
way ANOVA at each time point versus 0 min post-
bleach, * denotes p < 0.05, ** denotes p < 0.01, ***
denotes p < 0.001. Time points of significant differ-
ences of axonal fluorescence compared with cul-
tures treated with anisomycin and those trans-
fected with RanBP short 30UTR are indicated
by xx for p < 0.01 or xxx for p < 0.001.
(E) FRAP analyses in cut axons. Representative im-
ages from a cut axon FRAP sequence from DRG
neurons transfected with myr-dzGFP fused to the
long RanBP1 30UTR. The GFP fluorescence re-
covers in the distal bleached portionof the axon (ar-
rows) without any transition of GFP signals from the
proximal unbleached regions. Scale bar is 25 mm.
(F) Quantification of fluorescence after photo-
bleaching in cut axons. Average % of prebleach
levels ± SEM (n = 10). Significant recovery after
photobleaching assessed by one-way ANOVA at
each time point versus 0 min postbleach,
** denotes p < 0.01, *** denotes p < 0.001.Kif5C560-Tomato over 20 min after the bleach (Figure S6A).
Extrapolation from these data indicate that the earliest time
point one could start seeing new Kif5c560-dTomato arriving
in the bleached region is 64 min—at which time one would
already have observed complete recovery of dzGFP-long-
RanBP1-UTR from local translation. Finally, we devised a ‘‘dou-
ble-bleach’’ FRAP sequence to directly address the possibility
of lateral movement of the myristoylated reporter protein within
the axoplasmic membrane as well as other modes of transport
of myr-dzGFP. In this experiment, terminal segments of the
distal axons in intact neurons were photobleached as before,
and then the proximal half of the photobleached region was
continuously bleached while monitoring potential recovery in
the distal portion. We carried out such double-bleach experi-ments on neurons cotransfected with both dzGFP-long-
RanBP1-UTR and the Kif5c560-dTomato reporter and ob-
served clear recovery of the locally translated dzGFP (Figures
S6B and S6C; Movie S7) compared to no recovery for the
Kif motor reporter (Figure S6C). The complete recovery time
for dzGFP extracted from these data is 148 ± 11.6 min (corre-
lation coefficient = 0.96). Since any GFP molecules moving
down the axon would have been fully photobleached prior to
reaching this region, we conclude that the distal recovery
must be due to localized translation of myr-dzGFP localized
via the 30-RanBP1 UTR sequence. Taken together, these ex-
periments show conclusively that the complete FRAP recovery
of the construct fused to the long form of RanBP1 30UTR is due
to local synthesis.Neuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc. 245
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Ran Controls Axonal Retrograde Injury SignalingThe results described above suggest that retrograde injury
signaling may be regulated by the Ran system in peripheral
nerve. Under normal conditions, RanGTP bound to axonal CAS
and importins will prevent importin-a and -b interaction and bind-
ing of cargo proteins (Herold et al., 1998). Importin-b1 and
RanBP1 are found in the axon as mRNAs, and axonal RanBP1
mRNA is targeted to processes by a specific 30UTR sequence.
Following lesion, localized translation of these mRNAs leads to
upregulation of the corresponding proteins. The parallel and
more modest upregulation of soluble RanGAP in axoplasm
may be due to changed sequestration with membrane or cyto-
skeleton (Pay et al., 2002; Seewald et al., 2003), although this
remains to be determined. The newly synthesized RanBP1
stimulates disassociation of RanGTP and RanGAP synergized
hydrolysis, thus allowing formation of a cargo-binding complex
of importin-a with de novo synthesized importin-b (Figure 5).
In order to test the model outlined in Figure 5, we searched for
ways to specifically perturb Ran dynamics and functions in
axons, without interfering with critical roles of the Ran system
in nuclear import. An initial gain-of-function experiment was con-
ducted by trituration of RanBP1 protein into DRG neurons during
preparation for culture. This method was previously shown to in-
duce protein uptake into the lesioned axonal stump, thus allow-
Figure 5. Schematic Model of Ran Regulation of
Axonal Retrograde Signaling after Nerve Lesion
Under normal conditions (upper panel), RanGTP bound to ax-
onal CAS and importins will prevent importin-a and -b interac-
tion and binding of cargo proteins. Importin-b1 and RanBP1
are found in the axon as mRNAs. Following lesion (middle
panel), localized translation of these mRNAs leads to upregu-
lation of the corresponding proteins. The newly synthesized
RanBP1 stimulates disassociation of RanGTP and RanGAP
synergized hydrolysis, thus allowing formation of a cargo-
binding complex of importin-a with de novo synthesized
importin-b (lower panel).
ing rapid assessment of effects on process out-
growth (Hanz et al., 2003; Perlson et al., 2005).
Indeed, trituration of native RanBP1 by this method
induced robust neurite extension in comparison to
controls within the first 24 hr of culture (Figures 6A
and 6B). Control neurons, or neurons triturated with
heat-inactivated RanBP1, extended few or no neu-
rites early in the culture, but at later time points of
48 hr or more exhibited outgrowth similar to that
found in RanBP1-triturated cells (data not shown).
Thus, increasing the levels of RanBP1 at the site
of injury causes a transient acceleration of the in-
jury response, as predicted by the model.
Injection of proteins into sciatic nerve axons con-
comitantly with injury should enable perturbation of
the system in a spatially and temporally restricted
manner, as shown by injection of fluorescent
reporter proteins or the RanQ69L mutant
(Figure S7). We observed uptake of fluorescent
streptavidin (Figure S7) or IgG (data not shown)
into approximately 50% of the axons near the le-
sion site in crushed nerve. Levels of the introduced proteins de-
creased significantly within a few hours, as shown by immunos-
taining on cross-sections of the nerve (Figures S7A and S7B) and
by western blots on axoplasm (Figures S7C and S7D), indicating
that this approach allows transient and local interference with the
system. We therefore tested the effects of introducing the well-
characterized RanQ69L mutant, which binds GTP but cannot hy-
drolyze it to GDP (Stewart et al., 1998; Weis et al., 1996). Intro-
duction of excess RanQ69L-GTP to the axon should therefore
reduce interaction of importins-a and -b, while RanQ69L-GDP
should not interfere with formation of the importins complex.
RanQ69L preloaded with either GTP or GDP was injected to
the sciatic nerve concomitantly with a conditioning lesion (Smith
and Skene, 1997). Five days later, L4/L5 DRG neurons from the
treated animals were placed in culture, and axonal outgrowth
was assessed after 18 hr in vitro. The degree of outgrowth of
DRG neurons from animals treated with RanQ69L-GTP was sig-
nificantly lower than neurons from animals treated with either
RanQ69L-GDP or vehicle (Figures 6C and 6D). ELISA quantifica-
tion of the NLS-binding capacity associated with axoplasm dy-
nein under these different treatments confirmed that application
of RanQ69L-GTP markedly reduced the cargo binding capacity
of the retrograde complex in lesioned sciatic nerve axons246 Neuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc.
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Ran Controls Axonal Retrograde Injury SignalingFigure 6. Modulating the Ran System
Affects Neuronal Injury Responses
(A) Representative pictures of adult DRG neurons
24 hr in culture after trituration with 250 mg of re-
combinant RanBP1 or of heat-inactivated RanBP1
as control.
(B) Quantification of the fraction of neurite-bearing
cells (average ± standard deviation, n = 4), * de-
notes p < 0.05 (one-tailed t test).
(C) The GTP-loaded form of the nonhydrolyzable
Ran mutant RanQ69L inhibits the conditioning
lesion response in sensory DRG neurons. Thirty-
two micrograms of RanQ69L-GTP or RanQ69L-
GDP or vehicle control were injected to the sciatic
nerve concomitantly with a conditioning lesion.
Five days later, L4-L5 DRG neurons were placed
in culture, and neuronal outgrowth was examined
after 18 hr in vitro.
(D) Quantification of the experiments shown in (C).
The percent of outgrowth of DRG neurons from
animals treated with RanQ69L-GTP was signifi-
cantly lower than neurons from animals treated
with either RanQ69L-GDP or vehicle (average ±
standard deviation, n = 6). ** denotes p < 0.01
(Student’s t test).
(E) RanQ69L reduces formation of the retrograde
importins complex in sciatic nerve. The experiment
was carried out as detailed above, with the addition
of 30mg of biotinylated NLS peptide in the injection.
Axoplasm was extracted 6 hr later, subjected to
dynein immunoprecipitation followed by quantifi-
cation of bound NLS biotin by a streptavidin-HRP
ELISA (Student’s t test, p < 0.01, average ± stan-
dard deviation, n = 3).(Figure 6E). Finally, we examined the involvement of endogenous
Ran in regulation of retrograde injury signaling by testing the ef-
fects of blocking antibody injections in the conditioning lesion
paradigm in sciatic nerve. Two antibodies were tested, an anti-
RanBP1 antibody previously shown to interfere with RanBP1
function (Guarguaglini et al., 2000), and the anti-Ran antibody
ARAN1 that competes with the binding of RanBP1 to RanGTP
and should therefore prevent the disassembly of the RanGTP/
CAS/importin-a complex. Injection of the anti-RanBP1 antibody
or ARAN1 to sciatic nerve concomitantly with a crush injury sig-
nificantly reduced the level of conditionally lesioned neuronal
outgrowth in comparison to vehicle or irrelevant antibody con-
trols (Figures 7A and 7B). It is noteworthy that all the in vivo func-
tion-perturbing experiments carried out with RanQ69L or with
antibodies are done by introducing the reagent to axons in vivo
a number of days before readout of the eventual effect on neu-
rite-extension characteristics of the cell body. Since the half-
life of such reagents is measured in hours in vivo (Figure S7), it
follows that a perturbation at the initial stages of formation of
the complex is sufficient to affect retrograde injury signaling.
DISCUSSION
We have shown that Ran is found in both GTP- and GDP-bound
forms in sciatic nerve axons and that RanGTP is in association
with CAS, importin-a, and dynein in noninjured neurons. Upon
axonal injury, local translation of RanBP1 together with recruit-ment of axonal RanGAP facilitates dissociation of Ran from the
importin-a-dynein complex, and hydrolysis of RanGTP to GDP.
This allows binding of newly translated importin-b to importin-a
on dynein, thus creating a retrograde injury-signaling complex
ready to bind cargo. In vivo perturbation of this mechanism by in-
troducing a GTP-loaded nonhydrolyzable Ran mutant or block-
ing antibodies to Ran or RanBP1 to sciatic nerve concomitantly
with injury inhibits the conditioning lesion response of DRG sen-
sory neurons. These findings reveal a mechanism that regulates
initiation of retrograde injury signaling in peripheral sensory neu-
rons and unveil a new function for Ran in regulating transport in
the cytoplasm.
Ran Discriminates Different Modes
of Retrograde Signaling
A number of candidate retrograde injury signals have been sug-
gested in the literature, including Erk1/2, p38 MAPK, jun kinase
(Jnk), protein kinase A, protein kinase G, and the transcription
factors STAT3 and ATF2/3 (Hanz and Fainzilber, 2006 and refer-
ences cited therein). How does this diversity of cargos link to the
retrograde transport machinery? Apart from classical NLS-tar-
geted cargos that should bind the importin-a/b complex on dy-
nein, other cargo proteins can bind at distinct sites. For example,
calpain cleavage fragments of the intermediate filament vimentin
bind directly to importin-b and in parallel to phosphorylated Erks,
thus linking the latter to importin-mediated retrograde transport
(Perlson et al., 2005). Other candidate injury signals may link toNeuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc. 247
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(2005) have proposed the protein Sunday driver (Syd) as a linker
of activated Jnk3 to injury signaling, due to an apparently en-
hanced interaction between Syd and dynactin after injury. Dy-
nactin is also important for transport of growth factor signaling
endosomes on dynein, which is critical for neuronal survival
and maintenance (Bronfman et al., 2007; Ibanez, 2007). Thus,
different nonexclusive modes have been described for dynein
to interact with different cargos. Variability in subunit composi-
tion within the dynein complex might also allow for differential
cargo binding (Pfister et al., 2006), leading to different combina-
tions of signals being transported in different cell types. Clearly
regulation of cargo binding to the dynein motor is critical for neu-
ronal function, and RanGTP binding to importin-a and CAS on
Figure 7. Regulation of Retrograde Injury Signaling by the Ran
System
Anti-RanBP1 or anti-Ran (ARAN1) antibodies inhibit the conditioning lesion re-
sponse in sensory DRG neurons. Rat sciatic nerves were injected with vehicle
control or 10–20 mg of antibody, concomitantly with a crush lesion. IgG1 and
IgG2 are two unrelated control antibodies (anti-biotin and anti-GFP, respec-
tively). Five days later, L4-L5 DRG neurons were placed in culture.
(A) Representative images of neurons after 18 hr in culture.
(B) Quantification of the fraction of neurite-extending cells (average ± standard
deviation, n = 3). ** denotes significant difference from controls at p < 0.01 (Stu-
dent’s t test).248 Neuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc.dynein provides the system with a ‘‘safety catch’’ that prevents
formation of importin complexes, hence preventing inappropri-
ate retrograde transport of importin-dependent cargos. The lo-
calized upregulation of Ran hydrolyzing machinery provides tight
spatiotemporal control of system activation by releasing the Ran
‘‘safety catch.’’ Furthermore, Ran regulation of retrograde sig-
naling allows discrimination between importin-dependent and
importin-independent cargos, thus providing an additional layer
of flexibility to dynein-dependent retrograde signaling.
Localized Translation of RanBP1 Is Key for Activation
of Retrograde Injury Signaling
The ‘‘safety catch’’ mechanism for axonal Ran is based on low
hydrolysis of importin-bound RanGTP under normal conditions,
when axonal RanBP1 is low. Following injury, localized upregu-
lation of RanBP1 and RanGAP can ‘‘release the catch’’ by cata-
lyzing displacement and hydrolysis of Ran. RanBP1 influences
Ran-RanGAP interactions by order of magnitude increases of
the association and subsequent hydrolysis rates (Seewald
et al., 2003). Strict control of axonal RanBP1 levels by targeted
mRNA transport and localized translation upon need should
therefore be ideal for localized and dramatic changes in RanGTP
hydrolysis at a defined site in the axon. The calcium dependence
of this process likely enables its activation by calcium influx re-
sulting from nerve injury and potentially also from other stimuli.
The relative contributions of local axonal translation versus
transport of cell body synthesis products to the axonal protein
ensemble has been the topic of much debate (Wang et al.,
2007 and references cited therein). Much evidence has accumu-
lated in recent years in support of both mechanisms, and indeed
it has become clear that they are complementary and that the
degree of importance of one versus the other will differ between
different proteins and different physiological states of the
neuron. The principle utility of local translation to the retrograde
injury-signaling mechanism seems to be in allowing the cell to
maintain a signaling mechanism in a dormant state until needed,
as well as enabling rapid activation of the mechanism. This is ex-
emplified strikingly in the FRAP data of Figures 4 and S6, with full
local translation reporter fluorescence recovery over 50 min,
compared to essentially no recovery of an anterograde tran-
sport reporter within this time frame. RanBP1-induced hydroly-
sis of RanGTP to RanGDP occurs within 60 min of injury in vivo
(Figure 2); thus, the FRAP results show that localized translation
provides a sufficiently rapid mode of RanBP1 upregulation in this
case. Moreover, the functional perturbations by injecting anti-
bodies or dominant-negative Ran (RanQ69L) at the lesion site
shown in Figures 6 and 7 are dependent on reagents with
a half-life of less than 2 hr in the injured axons, as shown in Fig-
ure S7. The injury site in our experiments in rat sciatic nerve is ap-
proximately 5 cm distant from the corresponding neuronal cell
bodies. The fastest anterograde transport velocities reported in
the literature are 4.5 mm/s (Kaether et al., 2000). This velocity
is beyond that achievable by a single motor, and seems to arise
from multiple motors coordinating transport of an individual
cargo (Kural et al., 2005). Even if such uniquely rapid transport
mechanisms are activated after nerve injury, the maximal dis-
tance covered at these velocities will be approximately 1 cm/
hr, under an optimistic 60%/40% estimate of the go/stop ratio.
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driven transport of RanBP1 from the cell body can account for
events initiated within minutes after injury and essentially com-
pleted within two hours at this 5 cm distant lesion site. Finally, al-
though local axonal translation capacity is thought to be 10-fold
less per volume unit than that of the cell body (Lee and Hollen-
beck, 2003), the data of Hanz et al. (2003) and of Figure 6E sug-
gest that the concentration of functional importin complexes in
axoplasm reaches 0.2 pM, which is three to six orders of mag-
nitude less than concentrations of importin-b in cell body cyto-
plasm of nonneuronal cells (Yang and Musser, 2006). Given sto-
chiometric equivalency of RanBP1 and importins, this suggests
that local translation capacity in peripheral axons is more than
sufficient to account for physiologically relevant levels of local
upregulation of RanBP1 upon injury.
RanGTP in Axons: Implications and Speculations
One of the most striking aspects of the above data is that
RanGTP is found in axonal cytoplasm in the sciatic nerve. The
strict nuclear localization of RCC1, the only known RanGEF, cou-
pled with RanBP1 and RanGAP in the perinuclear region of the
cytoplasm, creates a nuclear RanGTP versus cytoplasmic
RanGDP gradient in cells, the steepness of which is determined
by cytoplasmic RanBP1 and RanGAP levels (Gorlich et al., 2003).
The occurrence of RanGTP in axons might be explained by two
mechanisms, both entirely speculative at this time. Facilitated
transport of RanGTP from the nucleus in parallel with its pro-
tection from hydrolysis might be one such mechanism. Al-
ternatively, a hitherto unrecognized RanGEF might regenerate
RanGTP in the axon. In this context, it is interesting to note
that RCC1 in plants has so far not been identified by sequence
homology (Meier, 2007), so the existence of very divergent Ran-
GEFs is not inconceivable. Notably, splice variants of RCC1
might be found at low levels in the cytoplasm under certain con-
ditions (Hood and Clarke, 2007). A number of cytoplasmic pro-
teins containing RCC1-like domains have been described, al-
though RanGEF activity has not been established for any of
them. The multidomain GEF protein alsin/ALS2 is of particular in-
terest due to its linkage to motor neuron disease (Hadano et al.,
2007). A recent study identified a homozygous missense muta-
tion in the RCC1 domain of alsin in a patient suffering from juve-
nile primary lateral sclerosis and showed mislocalization and cy-
totoxicity of the mutant protein in neurons (Panzeri et al., 2006).
However, we were not able to demonstrate in vitro RanGEF ac-
tivity of recombinant alsin (data not shown), and the provocative
hypothesis of an axonal RanGEF requires further study.
General Roles for Importins and Ran in Neurons
While we have established a role for importins in the transport of
injury signals from axonal lesion sites to the cell body in injured
peripheral sensory neurons (Hanz et al., 2003; Perlson et al.,
2005), others have demonstrated roles for importins in cytoplas-
mic transport of synaptic signals in central neurons (Thompson
et al., 2004), and in tiling of photoreceptor axons in development
of the Drosophila visual system (Ting et al., 2007). In addition,
a switch in the subtypes of importin-a expressed in embryonic
stem cells may be critical for neuronal differentiation (Yasuhara
et al., 2006), since the importin-a switch may dictate changesin the spectrum of cargo transcription factors imported into the
nucleus (Shmidt et al., 2007; Yasuhara et al., 2006; Yasuhara
and Yoneda, 2007). The Ran interactor RanBPM also influences
neuronal differentiation in conjunction with TAF4 in embryonic
cortical neural stem cells (Brunkhorst et al., 2005). Most recently,
RanBPM was implicated in axon guidance as a modulator of
semaphorin 3A signaling via an interaction with Plexin-A recep-
tors (Togashi et al., 2006). Intriguingly, Ran is known to regulate
microtubule dynamics and organization during spindle formation
in mitosis (Ciciarello et al., 2007; Kalab et al., 2002; Pay et al.,
2002), thus RanBPM and Ran might link axon guidance recep-
tors to microtubule functions in growth cones and in axons.
Clearly, Ran and its associated effectors and interactors are
involved in neuronal physiology from the tip of the growth cone
to the nuclear center of the cell body. We suspect that axonal
regulation of the GTP-bound state of Ran will prove to be critical
for the development and maintenance of neuronal projections
under normal conditions as well as in response to injury.
EXPERIMENTAL PROCEDURES
Nerve Injury and Axoplasm Preparation
Sciatic nerve crush was carried out on anesthetized adult male Wistar rats, and
axoplasm was prepared in nuclear transport buffer (NTB, 20 mM HEPES/KOH
[pH 7.3], 110 mM Kac, 5 mM MgAc, 0.5 mM EGTA) were as previously de-
scribed (Hanz et al., 2003; Perlson et al., 2005).
Antibodies and Immunofluorescence
The hSRPg antibody against importin-a4 was a kind gift from Dr. Karsten Weis
(UC Berkeley). Goat anti-RanGAP was a kind gift from Dr. Frauke Melchior
(University of Go¨ttingen). Rabbit anti-Ran was from Abcam (Cat. #31118);
mouse anti-importin-b1 clone 3E9 was from Affinity Bioreagents; mouse
anti-dynein intermediate chain clone 74.1 was from Chemicon (MAB1618),
rabbit anti-NF-H was from Chemicon (AB1989); mouse anti-NF-H clone N52
was from Sigma; goat anti-RCC1 (SC-1162), Goat anti-RanBP1 (SC-1159),
and goat anti-CAS (SC-1708) were from Santa Cruz; mouse Ran clone 20
and mouse CAS clone 24 were obtained from Transduction Labs. Anti-
Sumo-1 monoclonal 21C7 was purchased from Zymed. The ARAN1 antibody
was prepared as previously described (Hieda et al., 1999). Cultured DRG neu-
rons were fixed with 3% paraformaldehyde for immunostaining. Control and
injured sciatic nerve segments were fixed in 4% paraformaldehyde, frozen,
and sectioned at 15 mm thickness.
Immunoprecipitation
For immunoprecipitations, axoplasm from control or lesioned nerve was pre-
cleared for 1hr with Protein G Sepharose. Following overnight incubation
with primary antibody (quantity as per manufacturer’s specifications), com-
plexes were incubated with protein G Sepharose beads for 2 hr at 4C and
then precipitated and washed with NTB. Proteins were eluted by boiling and
subjected to western blot. When crosslinked antibody was used, samples
were eluted with stripping buffer (0.1 M NaCl, 0.15 M glycine [pH 3]). Precipi-
tation with ARAN1 antibody was carried out using 10 mg of ARAN1 for 200 mg
axoplasm. For immunoprecipitation of RanGTP from axoplasm, 200 mg axo-
plasm were mixed with 10 mg His-importin-b and 10 mg ARAN1 and incubated
at 4C for 2 hr, followed by precipitation of the complex with 20 mg Protein G
Sepharose.
Local Protein Synthesis in Axoplasm
Sciatic nerves were injected with 15 ml of 10 mg/ml of cycloheximide or 100 mM
EGTA. Axoplasm was resolved on SDS-PAGE gel and blotted for RanBP1,
RanGAP, and importin-b.Neuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc. 249
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Isolation of DRG axons and cell bodies was carried out as previously described
(Zheng et al., 2001). Two hundred nanograms of RNA from cell body and axons
was used as template for reverse transcription and PCR. RanBP1 primers
were as follows: GCCGCCAAGAGGACAGTC and CATGAGAAGGCGGA
TGGT; for RanGAP GGGCAAGGGTCTCAAACT and AGCCTCGCACTCCATC
AG. b-actin and g-actin served as positive and negative controls, as previously
described (Zheng et al., 2001).
Fluorescent In Situ Hybridization
FISH for endogenous RanBP1 was performed according to the methods of
Bassell and colleagues (1998) with minor modifications. Two oligonucleotide
probes complementary to RanBP1 (at positions 299–345 and 457–506) were
designed using Oligo 6 analysis software and checked for homology to other
mRNAs by BLAST. Probes were synthesized with amino group modifications
at four positions each and labeled with digoxigenin (DIG) succinamide ester
per manufacturer’s instructions (Roche Applied Science). Eighteen hour
cultures of seven day injury-conditioned DRGs were fixed in buffered 4% para-
formaldehyde, equilibrated in 13 SSC with 40% formamide, and incubated at
37C for 12 hr in hybridization buffer (40% formamide, 0.4% BSA, 20 mM
ribonucleotide vanadyl complex, salmon testes DNA [10 mg/ml], E. coli
tRNA [10 mg/ml], and 10 mM sodium phosphate in 13 SSC) containing 20
ng probe. Hybridization was detected by immunofluorescence using Cy3-
conjugated mouse anti-digoxigenin (1:1000; Jackson ImmunoResearch);
neurofilament protein was detected by colabeling with chicken anti-NFH
(1:1000; Chemicon) followed by FITC conjugated anti-chicken antibody
(1:500; Jackson ImmunoResearch). Oligonucleotide probes complementary
to b-actin mRNA (at positions 3187–3138 and 3446–3495) were used as a
positive control and scrambled probes were used to control for nonspecific
binding. FISH/IF signals were analyzed on an inverted Leica TCS/SP2 confocal
microscope.
FISH for GFP reporter constructs was carried out with a GFP riboprobe, pre-
pared by PCR using the following primers: forward 50-AGTGCTTCAGCCGC
TACCC-30, reverse 50-CGGTCACGAACTCCAGCA-30. The resulting 415 bp
product was subcloned into a pGEM vector, linearized with BamHI, and the
DIG-tagged RNA probe was transcribed in vitro using T7 polymerase. The
probe was used for hybridization at 50 mg per slide. Hybridization was con-
ducted for 5 hr at 55C in wet chambers, followed by overnight incubation
with an anti-DIG monoclonal antibody (1:500, Enzo, Roche). Signal was de-
tected by 45 min incubation with an anti-mouse Cy5-labeled secondary anti-
body (1:1000, Jackson), with imaging by confocal microscopy as described
above.
Fluorescence Recovery after Photobleaching (FRAP)
Dissociated DRG cultures from adult Sprague Dawley rats were transfected
with myr-dzGFP-RanBP1 or Kif5C560-Tomato plasmids prior to plating using
an Amaxa Nucleofection system. FRAP was performed using a Leica TCS-SP2
confocal microscope fitted with an environmental chamber to cells at 37C,
5% CO2. Forty-eight to seventy-two hours after transfection, GFP-expressing
neurons were chosen for FRAP analyses. 403 oil immersion objective (numer-
ical aperture = 0.7) was used for imaging with the pinhole of the confocal set to
4 airy units to ensure that the entire thickness of axons (2–4 mm diameter) was
exposed to laser emission. All experiments employed the 488 nm laser line for
GFP excitation and photobleaching with energies as indicated below. Excita-
tion and photobleaching for Tomato was performed with 543 nm laser line set
to 100% and 50% energy, respectively. GFP emission was collected with
a band filter set to 498–530 nm with PMT energy, offset, and gain matched
for all collection sets; collection of tomato signals was with band filter set to
595–640 nm. Prior to photobleaching, neurons were imaged every 30 s for
15 min with 15% laser power. A region of interest (ROI) of the terminal axon
was then exposed to 75% laser power for 40 frames at 3.2 s intervals. Recov-
ery of GFP emission was then monitored every 30 s over 30 min using 15% la-
ser power. The raw data from multiple time-lapse experiments was used to
calculate from matched images for the bleached ROI. In some experiments,
cultures were pretreated with 1–10 mM anisomycin immediately before imag-
ing (i.e., at ‘‘prebleach’’) as indicated.250 Neuron 59, 241–252, July 31, 2008 ª2008 Elsevier Inc.Double-Bleach FRAP Sequence
A double-bleach FRAP sequence was used to fully remove any GFP derived
from proximal sources over the course of recovery. The advanced time-lapse
module of the LSC was customized for this FRAP sequence. For this, an ROI
that included the growth cone and more proximal axon shaft was imaged every
30 s for 5.5 min at 7% laser power (lapse 1). This ROI was roughly twice the size
of the typical FRAP experiments outlined above. The entire ROI was then pho-
tobleached by 40 successive scans (typical duration was 58–60 s) at maximum
speed with 100% laser power (lapse 2). Photobleaching was confirmed by rap-
idly acquiring a single image at 7% laser power (lapse 3). Photobleaching was
then maintained in the proximal 1⁄2 of the ROI (i.e., axonal shaft excluding ter-
minal axon) for 15 successive scans at 2 s intervals with 40%–70% power
(lapse 4). The remainder of the ROI from lapse 1 (i.e., terminal axon) was not
subjected to bleaching during this lapse 4. Upon completion of lapse 4, recov-
ery of fluorescence was monitored by imaging the entire ROI at 7% laser
power (lapse 5). Lapses 4 and 5 were then repeatedly cycled for 100 times,
to give a 30 min duration for postbleaching.
FRAP Analyses of Severed Axons
To eliminate the neuronal cell body’s contribution to fluorescence recovery
after photobleaching, axons were disconnected from the cell body by me-
chanical transection. Briefly, a micropipette was drawn from a glass capillary
using a Sutter Instruments P87 pipette puller (South San Francisco, CA) and
mounted on a motorized micromanipulator attached to the stage of an inverted
microscope. The tip of the mounted micropipette was placed in contact with
the bottom of the coverslip and quickly moved across the axon shaft (left to
right). Complete transaction was verified both by DIC and compression of ax-
onal GFP signals upon retraction of the cut ends. These pre- and posttransec-
tion DIC and fluorescent images were taken with 15% power on 488 nm laser.
After verifying complete transection, the field of view was zoomed 3–4 times
for FRAP sequences. Prebleach images of the distal axon were then taken ev-
ery 30 s for 5 min at 15% laser power. The distal segment of the cut axon was
then photobleached at 100% laser power at maximum scanning speed for 40
successive scans. Fluorescence recovery was monitored at 30 s intervals with
15% laser power for 30 min. Only the transected axons that showed no obvi-
ous disintegration (varicosity or blebbing) or detachment from the bottom of
the culture vessel were utilized for computing the ROI mean value and pooled
for analysis.
Quantification of FRAP and Statistical Analysis
Image processing and analysis was performed using ImageJ software (NIH,
Bethesda, MD). To calculate the mean fluorescence intensity within an ROI
that encompassed the terminal axon with growth cone, total fluorescence in-
tensity of the ROI for each time was divided by overall area of the ROI. The per-
centage of fluorescence recovery at each time point after photobleaching was
then normalized to the baseline of the mean fluorescence intensity that had
been measured within the ROI of the very first image after photobleaching (0
min) and averaged for all FRAP analyses in a transfection or a treatment. For
each construct tested, FRAP was analyzed on at least three neurons per
well and repeated over two transfection runs. Data was analyzed using Graph-
Pad Prism 4 software package (San Diego, CA). Two-way ANOVA was used to
compare the time for the recovery between transfections and between treat-
ments followed by Bonferroni post hoc multiple comparisons. All values
were expressed as mean ± SEM and significance was set at p < 0.05.
Conditioning Lesion
Sciatic nerve conditioning lesion was performed as previously (Hanz et al.,
2003), with concomitant injection of 2.2 mg of ARAN1, irrelevant (anti-biotin) an-
tibody or vehicle per nerve. In another set of experiments 32 mg of RanQ69L-
GTP or RanQ69L-GDP or vehicle were introduced per nerve. Five days after
injury, dissociated cultures were prepared from the L4-5 DRGs as described
(Hanz et al., 2003). After, 18 hr cultures were fixed in 3% paraformaldehyde,
stained with NF-H, and length of the longest axon per neuron was measured.
Between 50 and 250 cells were measured for each experimental repeat.
Trituration of DRG Neurons
DRG neurons were triturated in 0.5 ml HBSS containing 250 mg of recombinant
RanBP1 (Cytoskeleton RN07). The same amount of RanBP1 was boiled 10 min
and used as a negative control. Neurite outgrowth was scored after 24 and 48
Neuron
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repeat.
Quantification of NLS Binding of Dynein-Bound Complexes
Rat sciatic nerves were lesioned by crush and injected with 30 mg biotinylated
NLS (biotin-CTPPKKKRKV) together with 32 mg of RanQ69L-GTP or RanQ69L-
GDP or vehicle. After 6 hr the rats were sacrificed and sciatic nerve axoplasm
was precipitated on anti-dynein, followed by incubation with 100 ng of strep-
tavidin-HRP. Beads were washed and resuspended in NTB buffer and HRP
activity was assayed as described (Hanz et al., 2003).
Production of Recombinant Proteins
A construct for bacterial overexpression of His-tagged RanQ69L was kindly
provided by Dr. Ziv Reich (Weizmann Institute). Induction was done with 4
mM IPTG for 3 hr at 30C. Proteins were purified over a Nickel-NTA Agarose
column. The recombinant proteins were equilibrated in loading buffer (200
mM PIPES [pH 6.6], 10 mM EDTA, 10% glycerol, 1 mM DTT). The RanQ69L
proteins were loaded with either GTP or GDP. One milligram of protein was
incubated for 30 min at 4C with loading buffer containing 2.5 mM GTP or
GDP, followed by 15 min at room temperature. Then MgCl2 was added to final
concentration of 25 mM.
RanGTP Pull-Down from Axoplasm
Three hundred micrograms axoplasm (3–4 mg/ml) were mixed with 10 mg of re-
combinant His-tagged importin-b and incubated for 1 hr in 4C. Following the
incubation, 10 ml of NiNTA agarose beads (QIAGEN) were added to the axo-
plasm-importin mixture and incubated with rotation for 1.5 hr in 4C. Beads
were washed and the bound fraction was eluted with 300 mM imidazol. The
eluate was then separated on 10% SDS-PAGE and immunodetected with
Ran antibody (BD Transduction Labs monoclonal mouse antibody cat
#610341, 50 ng/ml).
Recombinant RanGTP-Importin-b Binding Assay
Four micrograms of importin-b and 1 mg of Ran, precharged with GTP or GDP,
were incubated at 4C for 1 hr in final volume of 100 ml. After the incubation,
1 mg of importin-b antibody (Sigma clone 31h4 cat#I2534) was added for an-
other 1.5 hr. Then the antibody was precipitated by 10 ml protein G Sepharose
(Amersham) with rotation of 1 hr at 4C. Beads were washed; the bound frac-
tion was eluted by boiling with SDS sample buffer and separated on 10% SDS
PAGE with subsequent immunodetection with anti-Ran (BD Transduction
Labs monoclonal mouse antibody cat #610341, 50 ng/ml).
SUPPLEMENTAL DATA
The Supplemental Data include seven figures and seven movies and can be
found with this article online at http://www.neuron.org/cgi/content/full/59/2/
241/DC1/.
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